Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers

ConclusionSYM-1219 is a valuable single-dose treatment option for women with BV that will not interfere with combined oral contraceptive methods.FundingSymbiomix Therapeutics.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research